| 摘要 |
THE PRESENT INVENTION PROVIDES AN ESSENTIALLY NONAQUEOUS, LIQUID PHARMACEUTICAL CONCENTRATE COMPOSITION FOR ORAL ADMINISTRATION CONTAINING SERTRALINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ONE OR MORE PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS. THE PRESENT INVENTION ALSO PROVIDES A USE OF THIS CONCENTRATE COMPOSITION TO PREPARE AN AQUEOUS SOLUTION OF SERTRALINE. IN ADDITION, THE PRESENT INVENTION PROVIDES A METHOD OF USING THIS CONCENTRATE COMPOSITION TO TREAT OR PREVENT A VARIETY OF DISEASES OR CONDITIONS. FINALLY, THE PRESENT INVENTION PROVIDES THE COMPOUND, (IS-CIS)-4- (3,4-DICHLOROPHENYL)-L ,2,3,4-TETRAHYDRO-N-METHYL-L-NAPHTHALENAM INE METHANESULFONATE.
|
